JNPMEDI signed a Memorandum of Understanding (MOU) with Yonsei University’s College of Pharmacy on November 8th to facilitate practical training and research collaboration using JNPMEDI’s clinical trial data management solution, Maven CDMS.
The signing ceremony, held at Yonsei University’s International Campus in Songdo-dong, Incheon, involved key officials from Yonsei University’s College of Pharmacy and representatives from JNPMEDI. The agreement aims to enhance practical understanding through hands-on training and establish a mutually beneficial cooperation framework for digitizing clinical trials research.
This partnership will involve ▲ the development and implementation of practical training programs, ▲ collaborative research initiatives, and ▲ other areas identified as mutually essential by both entities.
HyeYoung Kang, the Dean of Yonsei University’s College of Pharmacy, expressed enthusiasm, highlighting how the collaboration with JNPMEDI could significantly bolster the practical capabilities of pharmacy students. She aims to establish a model of successful industry-academia cooperation through joint research efforts in clinical trial fields.
Kwunho Jeong, CEO of JNPMEDI, emphasized the meaningfulness of partnering with Yonsei University’s College of Pharmacy. He envisions active talent cultivation through the college and aims to contribute to building a digital-based collaborative model for the forthcoming Songdo Severance Hospital’s informatization, utilizing JNPMEDI’s technological expertise.
Yonsei University College of Pharmacy, established in 2011 at Songdo International Campus, focuses on producing outstanding pharmacists and researchers in fields such as new drug development, clinical pharmacology, and health social pharmacy. The College has been actively pursuing to establish a model of medical-pharmaceutical cooperation with Yonsei University College of Medicine and Severance Hospital, aiming to become a role model in the healthcare and medical fields.
JNPMEDI, founded in 2020 with a developer-centered approach, aims to innovate the clinical trial industry through digital technology. The company has developed Maven Clinical Cloud, a clinical trial data management platform applicable to various medical fields such as pharmaceuticals, biotechnology, medical devices, and digital therapeutics. JNPMEDI is also recognized as a pioneer in advancing the decentralized clinical trials (DCT) market.
JNPMEDI signed a Memorandum of Understanding (MOU) with Yonsei University’s College of Pharmacy on November 8th to facilitate practical training and research collaboration using JNPMEDI’s clinical trial data management solution, Maven CDMS.
The signing ceremony, held at Yonsei University’s International Campus in Songdo-dong, Incheon, involved key officials from Yonsei University’s College of Pharmacy and representatives from JNPMEDI. The agreement aims to enhance practical understanding through hands-on training and establish a mutually beneficial cooperation framework for digitizing clinical trials research.
This partnership will involve ▲ the development and implementation of practical training programs, ▲ collaborative research initiatives, and ▲ other areas identified as mutually essential by both entities.
HyeYoung Kang, the Dean of Yonsei University’s College of Pharmacy, expressed enthusiasm, highlighting how the collaboration with JNPMEDI could significantly bolster the practical capabilities of pharmacy students. She aims to establish a model of successful industry-academia cooperation through joint research efforts in clinical trial fields.
Kwunho Jeong, CEO of JNPMEDI, emphasized the meaningfulness of partnering with Yonsei University’s College of Pharmacy. He envisions active talent cultivation through the college and aims to contribute to building a digital-based collaborative model for the forthcoming Songdo Severance Hospital’s informatization, utilizing JNPMEDI’s technological expertise.
Yonsei University College of Pharmacy, established in 2011 at Songdo International Campus, focuses on producing outstanding pharmacists and researchers in fields such as new drug development, clinical pharmacology, and health social pharmacy. The College has been actively pursuing to establish a model of medical-pharmaceutical cooperation with Yonsei University College of Medicine and Severance Hospital, aiming to become a role model in the healthcare and medical fields.
JNPMEDI, founded in 2020 with a developer-centered approach, aims to innovate the clinical trial industry through digital technology. The company has developed Maven Clinical Cloud, a clinical trial data management platform applicable to various medical fields such as pharmaceuticals, biotechnology, medical devices, and digital therapeutics. JNPMEDI is also recognized as a pioneer in advancing the decentralized clinical trials (DCT) market.